These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 1795632
1. Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization. Guiso N, Szatanik M, Rocancourt M. Microb Pathog; 1991 Dec; 11(6):423-31. PubMed ID: 1795632 [Abstract] [Full Text] [Related]
2. CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Betsou F, Sebo P, Guiso N. Infect Immun; 1993 Sep; 61(9):3583-9. PubMed ID: 8359880 [Abstract] [Full Text] [Related]
3. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Infect Immun; 1993 Feb; 61(2):486-90. PubMed ID: 8423077 [Abstract] [Full Text] [Related]
4. Cyclic AMP-Elevating Capacity of Adenylate Cyclase Toxin-Hemolysin Is Sufficient for Lung Infection but Not for Full Virulence of Bordetella pertussis. Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P. Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396322 [Abstract] [Full Text] [Related]
5. The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Betsou F, Sebo P, Guiso N. Infect Immun; 1995 Sep; 63(9):3309-15. PubMed ID: 7642260 [Abstract] [Full Text] [Related]
6. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor. Novotny P, Chubb AP, Cownley K, Montaraz JA, Beesley JE. Dev Biol Stand; 1985 Sep; 61():27-41. PubMed ID: 2872113 [Abstract] [Full Text] [Related]
7. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Guiso N, Rocancourt M, Szatanik M, Alonso JM. Microb Pathog; 1989 Nov; 7(5):373-80. PubMed ID: 2622329 [Abstract] [Full Text] [Related]
8. Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Gross MK, Au DC, Smith AL, Storm DR. Proc Natl Acad Sci U S A; 1992 Jun 01; 89(11):4898-902. PubMed ID: 1594590 [Abstract] [Full Text] [Related]
9. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Khelef N, Sakamoto H, Guiso N. Microb Pathog; 1992 Mar 01; 12(3):227-35. PubMed ID: 1614333 [Abstract] [Full Text] [Related]
10. Characterization of Post-Translational Modifications and Cytotoxic Properties of the Adenylate-Cyclase Hemolysin Produced by Various Bordetella pertussis and Bordetella parapertussis Isolates. Bouchez V, Douché T, Dazas M, Delaplane S, Matondo M, Chamot-Rooke J, Guiso N. Toxins (Basel); 2017 Sep 26; 9(10):. PubMed ID: 28954396 [Abstract] [Full Text] [Related]
11. Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin. Gueirard P, Guiso N. Infect Immun; 1993 Oct 26; 61(10):4072-8. PubMed ID: 8406794 [Abstract] [Full Text] [Related]
12. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Osicka R, Osicková A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. Infect Immun; 2000 Jan 26; 68(1):247-56. PubMed ID: 10603395 [Abstract] [Full Text] [Related]
13. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL. Infect Immun; 1999 May 26; 67(5):2090-5. PubMed ID: 10225859 [Abstract] [Full Text] [Related]
14. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Watanabe M, Nagai M. Infect Immun; 2001 Nov 26; 69(11):6981-6. PubMed ID: 11598073 [Abstract] [Full Text] [Related]
15. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J. Vaccine; 2004 Oct 22; 22(31-32):4270-81. PubMed ID: 15474718 [Abstract] [Full Text] [Related]
16. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis. Alvarez Hayes J, Oviedo JM, Valdez H, Laborde JM, Maschi F, Ayala M, Shah R, Fernandez Lahore M, Rodriguez ME. Microbiol Immunol; 2017 Oct 22; 61(10):407-415. PubMed ID: 28857261 [Abstract] [Full Text] [Related]
17. Antibodies to Bordetella pertussis adenylate cyclase toxin in neonatal and maternal sera. Arciniega JL, Hewlett EL, Edwards KM, Burns DL. FEMS Immunol Med Microbiol; 1993 Apr 22; 6(4):325-30. PubMed ID: 8499896 [Abstract] [Full Text] [Related]
18. Role of systemic and mucosal immune responses in reciprocal protection against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Watanabe M, Nagai M. Infect Immun; 2003 Feb 22; 71(2):733-8. PubMed ID: 12540552 [Abstract] [Full Text] [Related]
19. Cloning and sequence of the Bordetella bronchiseptica adenylate cyclase-hemolysin-encoding gene: comparison with the Bordetella pertussis gene. Betsou F, Sismeiro O, Danchin A, Guiso N. Gene; 1995 Aug 30; 162(1):165-6. PubMed ID: 7557410 [Abstract] [Full Text] [Related]
20. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Willems RJ, Kamerbeek J, Geuijen CA, Top J, Gielen H, Gaastra W, Mooi FR. Vaccine; 1998 Feb 30; 16(4):410-6. PubMed ID: 9607064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]